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SNPWe present histological, immunohistochemical and molecular features of oncocytic papillary
cystadenocarcinoma, a rare neoplasm of the salivary and parotid glands, in an 82-year-old Japanese man. The
resected tumor was solid nodular mass with ﬁbrous capsule. The tumor was composed of papillary proliferation
of tall columnar cells with thin vascular cores. The cytoplasm of the tumor cells was granular and eosinophilic.
The tumor cells showed clear positive reaction for mitochondria and androgen receptor. GCDFP15 and HER2
were negative. Electron microscopy demonstrated numerous mitochondria in the cytoplasm of the tumor cells.
Ki-67 index was 30%. Most of the tumor cells were positive for TP53, and single nucleotide polymorphism was
found at codon 151. The invasion into the lymphatic spaces and capsulewas noted. Although recurrence andme-
tastasis were not noted at one and a half years after the resection, the patient needs to be followed up under care-
ful observation.Diag
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. This© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Papillary cystadenoma and cystadenocarcinoma are rare histological
subtypes of neoplasms of the salivary and parotid glands, and it consti-
tutes approximately 2% of malignant tumor [1]. Oncocytic variant of
these neoplasms is extremely rare. In the salivary and parotid glands,
to date, seven cases of oncocytic papillary cystadenoma (OPCA) [2–7]
and only two cases oncocytic papillary cystadenocarcinoma (OPCCa)
[8] were reported in the literature. The tumors are characterized by
the papillary growth of the cells with eosinophilic cytoplasm. However,
the immunohistochemical features and genetic alteration of these tu-
mors were not fully described. We here present the histopathological
and molecular features of OPCCa of the parotid gland.nostic Pathology, Nippon
, Japan. Tel.: +81 3 3822
is an open access article under2. Case report
2.1. Clinical history
An 82-year-old Japanese man complained of a ﬁrm nodular mass in
the left parotid region. Computed tomography showed a well-
circumscribed tumor at the middle to lower pole of the left parotid
gland. The size of the tumorwas approximately 45mm in diameter. Sys-
temic examination did not show distant metastasis or lymph node me-
tastasis. Fine needle aspiration cytology demonstrated the tumor cells
with oncocytic feature and mild atypia. The patient underwent partial
resection of the left parotid gland. The resected tumor was subjected
for the pathological examination, and a diagnosis of OPCCa was made.
The patient has been followed up without any additional treatment.
At one and a half years after the surgery, recurrence or metastasis is
not noted.
2.2. Pathologic ﬁndings
The resected tumor was a ﬁrmmass located in the lower part of the
left parotid gland, and the size was 45 mm in diameter. The tumor had
ﬁbrous capsule, and there was no invasion to the surrounding parotidthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Histological ﬁndings of the parotid tumor. (A) Low power image of the tumor. (B) Medium magniﬁcation depicted the papillary growth of the tumor. (C) High magniﬁcation of
papillae with lining of single layer of tall columnar cells. (D) Periodic acid-Schiff was negative in the tumor cells. (E and F) Invasion into the capsule (E, arrow head) and lymphatic
spaces (F, arrow heads) was noted.
19S. Kure et al. / Human Pathology: Case Reports 5 (2016) 18–22gland (Fig. 1A). Large cystic space was not evident inside of the tumor.
Necrosis was not found. The histology of the tumor is characterized by
proliferation of papillae, forming irregular slit-like spaces (Fig. 1B).
Mucus production and crystalloid materials were not found in the
spaces. The papillae had thin ﬁbrovascular core, and they were covered
with single layer of tall columnar epithelial cells with eosinophilic and
granular cytoplasm. The nuclei were round to oval, and nucleoli were
conspicuous (Fig. 1C). Pleomorphismof thenucleiwasnot seen, andmi-
tosis was 1/10 high power ﬁeld. The tumor cells were negative forperiodic acid-Schiff (Fig. 1D) andmucicarmine. Inﬁltration and aggrega-
tion of lymphoid cells were not observed. The tumor showed invasion
into the capsule (Fig. 1E) and lymphatic spaces (Fig. 1F).
2.3. Immunohistochemical ﬁndings
The immunohistochemical staining was performed by Ventana GX
System (Roche Diagnostics, K.K., Tokyo, Japan) with antibodies against
mitochondria (Abcam, Co., Tokyo, Japan), GCDFP15 (Leica
Fig. 2. Immunohistochemical ﬁndings. (A) The cytoplasm of the tumor cells was positive for anti-mitochondria antibody. (B) The cells were negative for GCDFP15. (C) Androgen receptor
was positive in the nucleus of the epithelial cells. (D) The cellmembrane of the columnar cells was faintly positive for HER2 (arrowheads). (E) Ki-67 indexwas approximately 30%. (F) The
epithelial cells were positive for TP53.
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Co., CA, USA), estrogen receptor (ER), progesterone receptor (PgR),
TP53 and Ki-67 (Dako Japan, KK, Tokyo, Japan). Immunostaining of
HER2was donewithHercepTest (Dako Japan, KK). Strong granular pos-
itive reaction for anti-mitochondrial antibody was found in the cyto-
plasm of the tall columnar cells (Fig. 2A). The cells were negative for
GCDFP15 (Fig. 2B). ARwas clearly positive in the nuclei of the epithelial
cells (Fig. 2C). Neither ER nor PgR was detected. A faint reaction for
HER2 was found on the cell membrane of some epithelial cells(Fig. 2D). Ki-67 index was 30% (Fig. 2E), and TP53 was positive in 90%
of the epithelial cells (Fig. 2F).
2.4. Electron microscopic ﬁndings
Pathological specimen was dewaxed, and it was processed and em-
bedded in Epon812 for the examination by electron microscopy (EM).
EM depicted the papillae lined with tall columnar cells (Fig. 3A). Most
of the cells had prominent nucleoli. The cytoplasm of the columnar
Fig. 3. Electron microscopic ﬁndings. (A) High magniﬁcation of proliferating papillae.
(B) The lining columnar epithelial cells were packed with numerous mitochondria
(arrow heads).
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ule was not identiﬁed in the tumor cells.
2.5. Sequencing of TP53 gene
Using DNA extracted from parafﬁn sections of tumor tissue, frag-
ments of exon 5–8 of TP53were ampliﬁed and sequenced. In the exon
5, substitution of nucleotide C to A, which causes substitution of
amino acid of proline to threonine at codon 151,was detected. Thismis-
sense mutation is known as single nucleotide polymorphism (SNP,
rs28934874).
3. Discussion
The current study, theﬁrst, demonstrated the histological and genet-
ic features of OPCCa of the parotid gland. The tumor was characterized
by papillary growth of tall columnar cells with eosinophilic cytoplasm.
The cells showed strong positive reaction with anti-AR and anti-
mitochondrial antibodies. The presence of numerous mitochondria in
the cytoplasmof the columnar cellwas further conﬁrmed byEM. The in-
vasion into the capsule and lymphatic spaces was noted by histological
examination. The invasionmay not be due to the displacement of tumorcells by aspiration cytology. The capsular invasion was found in the
inner side of the tumor, where the aspiration needle did not reach.
The lymphatic endothelial cells were conﬁrmed by immunostaining
with D2-40 (data not shown). This evidence prompted a diagnosis of
OPCCa.
To date, only two cases of OPCCa and seven cases of OPCA in the
salivary glands are reported in the literature [2–8]. Including the cur-
rent case, seven cases were male [2,5–8], and three cases were fe-
male [3,4,6]. There is no apparent trend of the age in the
development of the tumor. The pathogenesis and behavior of the
tumor are largely unknown. Since one case of OPCCa follows an ag-
gressive clinical course [8], it is necessary to elucidate the expression
and alteration of molecules related to the pathogenesis and behavior
of the tumor.
In the routine pathological diagnosis, it is essential to differentiate
OPCCa from Warthin tumor, papillary variant of acinic cell carcinoma,
salivary duct carcinoma, and mucoepidermoid carcinoma [10]. Careful
histological evaluation of lymphoid aggregation andmucousproduction
needs to be evaluated. Immunohistochemical examination of HER2 and
AR is also useful for the differential diagnosis of these neoplasms [11].
For the deﬁnitive diagnosis of OPCCa, it is necessary to demonstrate
the positive stainingwith anti-mitochondria antibody by immunostain-
ing or the presence of numerous mitochondria in the cytoplasm of the
tumor cells by EM.
The expression of AR in OPCCawas not described before. The associ-
ation between AR expression and oncocytic change of the tumor cells is
not known. The expression might be associated with male predomi-
nance of these rare histological subtypes of salivary tumor. It is plausible
that the strong expression of AR is involved in the pathogenesis or pro-
liferation of tumor cells, and the molecule may serve as a therapeutic
target of the tumor [9].
The malignant potential of OPCCa is not fully elucidated. In the
previous report, 8-year-old child followed an aggressive clinical
course, showing lymph node metastasis and multiple recurrences
[8]. Another case followed a favorable course at eight months after
the surgery. In the current case, although there was invasion into
the capsule and lymphatic spaces, recurrence and metastasis were
not noted at one and a half years after the resection. Follow-up dura-
tion may be too short to evaluate the prognosis. The tumor cells
showed strong reaction for TP53, and the sequencing of TP53 gene
disclosed the presence of SNP at codon 151. The SNP is suspected
to be pathogenic alteration in breast cancer [12]. The loss of hetero-
zygosity is not examined in the current case. The presence of SNP
may serve as a pathogenic background in the development of the
tumor in the current case.Acknowledgments
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